SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607950. A total of 4 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,651,452 | +7.5% | 376,600 | +1.5% | 0.15% | +12.5% |
| Q2 2023 | $42,475,468 | +88.1% | 370,900 | +126.4% | 0.14% | +65.9% |
| Q1 2023 | $22,576,554 | +51.2% | 163,800 | +42.2% | 0.08% | +134.3% |
| Q4 2022 | $14,927,616 | +83.7% | 115,200 | +56.7% | 0.04% | +118.8% |
| Q3 2022 | $8,125,000 | +59.6% | 73,500 | +8.2% | 0.02% | +100.0% |
| Q2 2022 | $5,090,000 | -11.4% | 67,900 | -7.6% | 0.01% | +33.3% |
| Q1 2022 | $5,742,000 | -37.7% | 73,500 | -28.2% | 0.01% | -14.3% |
| Q4 2021 | $9,212,000 | +10.1% | 102,300 | +13.0% | 0.01% | -22.2% |
| Q3 2021 | $8,369,000 | +10.0% | 90,500 | -7.6% | 0.01% | 0.0% |
| Q2 2021 | $7,611,000 | -52.1% | 97,900 | -54.0% | 0.01% | -62.5% |
| Q1 2021 | $15,875,000 | -49.3% | 213,000 | +16.0% | 0.02% | -55.6% |
| Q4 2020 | $31,302,000 | +47.0% | 183,600 | +21.1% | 0.05% | -19.4% |
| Q3 2020 | $21,289,000 | +39.8% | 151,600 | +59.6% | 0.07% | -4.3% |
| Q2 2020 | $15,232,000 | +18.0% | 95,000 | -28.0% | 0.07% | -33.3% |
| Q1 2020 | $12,912,000 | -57.7% | 132,000 | -44.2% | 0.10% | -49.5% |
| Q4 2019 | $30,531,000 | +98.0% | 236,600 | +15.6% | 0.21% | +66.4% |
| Q3 2019 | $15,418,000 | -46.6% | 204,700 | +7.7% | 0.12% | -52.1% |
| Q2 2019 | $28,871,000 | +108.8% | 190,000 | +63.8% | 0.26% | +69.5% |
| Q1 2019 | $13,826,000 | +13.2% | 116,000 | +3.7% | 0.15% | +45.3% |
| Q4 2018 | $12,212,000 | -33.1% | 111,900 | -1.1% | 0.11% | -26.4% |
| Q3 2018 | $18,267,000 | +24.4% | 113,100 | +1.8% | 0.14% | +14.3% |
| Q2 2018 | $14,685,000 | +246.5% | 111,100 | +94.2% | 0.13% | +193.0% |
| Q1 2018 | $4,238,000 | -47.6% | 57,200 | -60.6% | 0.04% | -24.6% |
| Q4 2017 | $8,084,000 | -68.1% | 145,300 | -74.0% | 0.06% | -75.2% |
| Q3 2017 | $25,379,000 | +758.6% | 559,500 | +538.0% | 0.23% | +641.9% |
| Q2 2017 | $2,956,000 | -39.1% | 87,700 | -46.5% | 0.03% | -45.6% |
| Q1 2017 | $4,854,000 | -73.5% | 164,000 | -75.4% | 0.06% | -67.8% |
| Q4 2016 | $18,296,000 | -70.3% | 667,000 | -33.5% | 0.18% | -73.5% |
| Q3 2016 | $61,600,000 | +158.7% | 1,003,100 | -19.7% | 0.67% | +137.2% |
| Q2 2016 | $23,811,000 | +478.1% | 1,248,600 | +491.8% | 0.28% | +386.2% |
| Q1 2016 | $4,119,000 | -55.3% | 211,000 | -11.7% | 0.06% | -46.8% |
| Q4 2015 | $9,217,000 | -28.1% | 238,900 | -40.2% | 0.11% | -38.4% |
| Q3 2015 | $12,818,000 | +77.7% | 399,200 | +68.4% | 0.18% | +75.2% |
| Q2 2015 | $7,212,000 | +324.5% | 237,000 | +85.3% | 0.10% | +274.1% |
| Q1 2015 | $1,699,000 | -66.7% | 127,900 | -63.7% | 0.03% | -64.9% |
| Q4 2014 | $5,105,000 | -19.2% | 352,800 | +17.9% | 0.08% | -20.6% |
| Q3 2014 | $6,315,000 | -40.4% | 299,300 | -15.8% | 0.10% | -40.5% |
| Q2 2014 | $10,593,000 | +19.1% | 355,600 | -3.9% | 0.16% | +8.7% |
| Q1 2014 | $8,896,000 | +18.6% | 370,200 | +0.6% | 0.15% | +32.7% |
| Q4 2013 | $7,498,000 | -51.1% | 368,100 | +13.4% | 0.11% | -61.6% |
| Q3 2013 | $15,336,000 | +91.6% | 324,700 | +54.3% | 0.29% | +49.2% |
| Q2 2013 | $8,006,000 | – | 210,400 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 962 | $16,401,000 | 0.61% |
| GROUP ONE TRADING, L.P. | 183,600 | $31,302,000 | 0.05% |
| SIMPLEX TRADING, LLC | 950 | $16,196,000 | 0.02% |
| JPMORGAN CHASE & CO | 417,600 | $71,197,000 | 0.01% |
| IMC-Chicago, LLC | 33,800 | $5,763,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |